维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="EILAT H"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Constructing and evaluating balanced portfolios of R&D projects with interactions:A DEA based methodology显示文摘	Eilat H Golany B Shtub A	2006	European Journal of Operational Research2006，172，3：	1
	2	Constructing and evaluating balanced portfolios of R&D projects with interactions:a DEA based methodology显示文摘	EILAT H GOLANY B SHTUB A	2006	European Journal of Operational Research2006，172，3：	1
	3	Prevention of systemic lupus erythematosus-like disease in (NZB × NZW) F1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic antibody 显示文摘	Eilat E Zinger H Nyska A	2002	J Clin Immunol2002，20，4：	1
	4	The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus显示文摘	Eilat E Dayan M Zinger H	2001	Proc Natl Acad Sci USA2001，98，3：	1
	5	The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus 显示文摘	Eilat E Dayan M Zinger H	2001	Proc Natl Acad Sci USA2001，98，：	1
	6	R&D project evaluation: An integrated DEA and balanced scorecard approach显示文摘	Eilat H Golany B Shtub A	2008	Omega2008，36，5：	1
	7	A peptide based on anti-DNA autoantibody downregulates matrix metalloproteinase 显示文摘	FABER-ELMANN A EILAT E Zinger H	2002	Clin Immunol2002，105，2：	1
	8	The mechanism by which a peptide based on complementarity-determining region1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus 显示文摘	Eilat E Dayan M Zinger H	2001	Proc Natl Acad Sci USA2001，98，3：	1
	9	Characterization and role in ex- perimental systemic lupus erythematosus of T-cell lines specific to peptides based on complementarity-determining region-1 and comple- mentarity-determining region-3 of a pathogenic anti-DNA monoclonal antibody显示文摘	Brosh N Eilat E Zinger H	2000	Immunology2000，99，2：	1
	10	Prevention of systemic lupus erythematosus-like disease in (NZBxNZW)F1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic autoantibody 显示文摘	Eilat E Zinger H Nyska A	2000	J Clin Immunol2000，20，4：	1
	11	Prevention of systemic lupus erythematosus like disease in (NZBxNZW)F1 mice by treating with CDR1 and CDR3-based peptides of a pathogenic autoantibody显示文摘	Eilat E Zinger H Nyska A	2000	J Clin Immunol2000，20，4：	1
	12	The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus显示文摘	Eilat E Dayan M Zinger H	2001	Proc Natl Acad Sci USA2001，98，3：	1
	13	显示文摘	Eilat E Dayan M Zinger H	2001	Proc Natl Acad Sci USA2001，98，3：	1
	14	显示文摘	Eilat E Zinger H Nyska A	2000	J Clin Immunol2000，20，4：	1
	15	R&D project evaluation: An integrated DEA and balanced scorecard approach显示文摘	Eilat H Golany B	2008	Omega: International Journal of Management Science2008，36，5：	1
	16	Constructing and evaluating balanced portfolios of R&D projects with interactions: A DEA based methodology显示文摘	Eilat H Golany B Shtub A	2006	European Journal of Operational Research2006，172，3：	1
	17	Constructing and evaluating bal- aneed portfolios of R&D projects with interactions: A DEA based methodology 显示文摘	EILAT H GOLANY B SHTUB A	2006	European Journal of Operational Research2006，172，3：	1
	18	R&D Project Evaluation: An Integrated DEA and Balanced Scorecard Approach 显示文摘	Eilat H B Golany A Shtub	2008	Omega International Journal of Management Science2008，36，5：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费